Minute Insight: FDA Approves First Fluorescent Imaging Agent For Ovarian Cancer
Executive Summary
On Target Laboratories’ Cytalux (pafolacianine) is now approved for adult patients with ovarian cancer as an adjunct for intraoperative identification of malignant lesions.